VIVOPOWER PLC (VIVO) Stock Price & Overview
NASDAQ:VIVO • GB00BD3VDH82
Current stock price
The current stock price of VIVO is 2.86 USD. Today VIVO is up by 32.41%.
VIVO Key Statistics
- Market Cap
- 125.863M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
VIVO Stock Performance
VIVO Stock Chart
VIVO Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to VIVO.
VIVO Earnings
VIVO Forecast & Estimates
6 analysts have analysed VIVO and the average price target is 34.68 USD. This implies a price increase of 1112.59% is expected in the next year compared to the current price of 2.86.
VIVO Groups
Sector & Classification
VIVO Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
VIVO Ownership
VIVO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 28.59 | 55.214B | ||
| COO | COOPER COS INC/THE | 14.29 | 13.753B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.67 | 12.783B | ||
| SOLV | SOLVENTUM CORP | 9.84 | 11.109B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.01 | 4.797B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.44 | 4.015B | ||
| ICUI | ICU MEDICAL INC | 15.88 | 3.195B | ||
| HAE | HAEMONETICS CORP/MASS | 10.41 | 2.633B | ||
| XRAY | DENTSPLY SIRONA INC | 7.97 | 2.29B | ||
| NEOG | NEOGEN CORP | 27.01 | 1.982B | ||
| UFPT | UFP TECHNOLOGIES INC | 18.65 | 1.462B | ||
| STAA | STAAR SURGICAL CO | 135.77 | 939.205M | ||
| BVS | BIOVENTUS INC - A | 11.73 | 760.823M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About VIVO
Company Profile
Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. The company is headquartered in Cincinnati, Ohio and currently employs 770 full-time employees. The firm is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized polymerase chain reaction (PCR) master mixes, and bioresearch reagents used by other diagnostic test manufacturers and researchers in immunological and molecular tests for human, animal, plant and environmental applications. The firm's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi'in, Israel. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; and Luckenwalde, Germany.
Company Info
IPO: 1986-07-29
VIVOPOWER PLC
3471 River Hills Dr
Cincinnati OHIO 45244 US
CEO: Jack Kenny
Employees: 770
Phone: 15132713700.0
VIVOPOWER PLC / VIVO FAQ
Can you describe the business of VIVOPOWER PLC?
Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. The company is headquartered in Cincinnati, Ohio and currently employs 770 full-time employees. The firm is engaged in the development, manufacture, sale and distribution of diagnostic testing systems and kits, primarily for certain gastrointestinal and respiratory infectious diseases, and elevated blood lead levels; and the manufacture and distribution of bulk antigens, antibodies, immunoassay blocking reagents, specialized polymerase chain reaction (PCR) master mixes, and bioresearch reagents used by other diagnostic test manufacturers and researchers in immunological and molecular tests for human, animal, plant and environmental applications. The firm's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi'in, Israel. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; and Luckenwalde, Germany.
Can you provide the latest stock price for VIVOPOWER PLC?
The current stock price of VIVO is 2.86 USD. The price increased by 32.41% in the last trading session.
Does VIVOPOWER PLC pay dividends?
VIVO does not pay a dividend.
What is the ChartMill technical and fundamental rating of VIVO stock?
VIVO has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is VIVOPOWER PLC worth?
VIVOPOWER PLC (VIVO) has a market capitalization of 125.86M USD. This makes VIVO a Micro Cap stock.
Can you provide the upcoming earnings date for VIVOPOWER PLC?
VIVOPOWER PLC (VIVO) will report earnings on 2023-05-04, after the market close.